Proficio Capital Partners LLC Nektar Therapeutics Transaction History

Proficio Capital Partners LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$16.91 - $36.27 $963 - $2,067	-57 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$31.0 - $36.3 $1,209 - $1,415	-39 Reduced 40.63%	57 $2,000
Q1 2019 May 13, 2019	BUY	$31.58 - $46.35 $378 - $556	12 Added 14.29%	96 $3,000
Q4 2018 Feb 08, 2019	BUY	$30.43 - $56.65 $2,556 - $4,758	84 New	84 $3,000
Q3 2018 Nov 13, 2018	SELL	$46.46 - $68.49 $1,068 - $1,575	-23 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$46.25 - $104.45 $1,063 - $2,402	23 New	23 $1,000

140

135M

32.8K

55.5K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $247M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of Proficio Capital Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Proficio Capital Partners LLC with notifications on news.